Reply to 'Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma'

Nat Commun. 2018 Jul 26;9(1):2922. doi: 10.1038/s41467-018-05048-0.

Nicolas Jacquelot^{1

2

3}, Laurence Zitvogel^{4

5

6

7}, Alexander M Eggermont²

¹ INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France.
² Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France.
³ Division of Molecular Immunology, The Walter and Eliza Hall Institute of Medical Research, 3052, Parkville, Victoria, Australia.
⁴ INSERM U1015, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France. laurence.zitvogel@orange.fr.
⁵ Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, 94805, Villejuif, France. laurence.zitvogel@orange.fr.
⁶ Faculté de Médecine - Université Paris-Saclay, Kremlin Bicêtre, 94276, France. laurence.zitvogel@orange.fr.
⁷ CIC Biotherapie IGR Curie, CIC1428, Gustave Roussy Cancer Campus, Villejuif, 94805, France. laurence.zitvogel@orange.fr.

No abstract available

Publication types